ÂÜÀòÂÒÂ×

Richard Del Mastro is a seasoned professional in the field of molecular diagnostics and product development, currently serving as Senior Director of R&D North America at Menarini Silicon Biosystems since June 2021. As Principal at Stratavate since August 2012, Richard has specialized in transitioning research companies to product development, emphasizing strategic planning, budgeting, and regulatory compliance for in-vitro diagnostic medical devices. Previous roles include Director of Biomarker Discovery Development at Progenity, Sr Manager of Assay Development at Beckman Coulter, Vice President of R&D at IMDx, Director of Research and Product Development at Life Technologies, and Director of the Molecular Therapeutics Division at AmberGen. Richard holds a PhD in Molecular Genetics from the University of Birmingham, where research focused on mapping the X-chromosome and analyzing genetic diseases.